The global custom antibody market is expected to grow in the upcoming years. Custom antibody has high specificity and selectivity. As compared to other antibodies the custom antibodies can be easily produced.
Antibodies are the hosts in the body which are produced by the body when foreign entities enter the human body. By using the antibodies producing process, custom antibodies can also be produced for treatments of specific infections or diseases. Custom antibodies can work well in both quantitative and qualitative immune-detection method. There are different varieties of antibodies available which include polyclonal and monoclonal antibodies, hybridoma antibodies, and others. The quality of custom-made antibodies is preferred by the end users, especially the catalog antibodies. Customized antibodies can be produced in a mouse, rat or hamster to meet the requirements by the host.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on the custom antibody market.
Top Impacting factors:
- The custom antibody market has experienced growth in the recent years due to factors such as increase in R&D activities and rise in funding from the government to carry out the research.
- Increase in therapeutics of antibodies and expansion of drug pipeline, rise in collaborations of industry and academic institutions for research are the factors responsible for the growth of custom antibody market.
- Rise in demand for protein therapeutics and production of custom antibodies is expected to drive the market growth.
- Monoclonal antibodies in recent years has experienced high success in both clinical and commercial ways.
- Restrain factors like high expenses in process and time required for production can restrict the market growth of the custom antibody market.
New Product Launch / News:
- In May 2020, Abcellera, announced that it has entered into a multi-year strategic research collaboration and license agreement with Eli Lilly and Company (Lilly) for the discovery of antibodies for up to nine Lilly-selected therapeutic targets. Lilly will have the rights to develop and commercialize therapeutic products resulting from the collaboration.
- In 2018, Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) developed in collaboration with Merck KGaA (Germany).
- In 2017, U.S.-based Gen Script company introduced a new custom rabbit mAb (monoclonal antibody) service. This mAb service was called MonoRab and was an important part of the premium antibody service portfolio of the company.
Key benefits of the report:
- This study presents the analytical depiction of the global custom antibody market along with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the custom antibody market share.
- The current market is quantitatively analyzed to highlight the custom antibody market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed custom antibody market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the custom antibody market Report:
- Which are the leading market players active in the custom antibody market?
- What current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What Segments and region will drive the market growth & why?
- Which are the major custom antibody services?
Custom Antibody Market Report Highlights
| Aspects | Details |
 By Service |
|
 By Type |
|
 By Source |
|
 By Application |
|
 By Indication |
|
 By End User |
|
 By Region |
|
 Key Market Players | Cell Signaling Technology, Inc, GenScript, Innovagen AB, Merck Group, Thermo Fisher Scientific Inc., Abcam Plc, PerkinElmer Inc., Bio-Rad Laboratories, Inc, Rockland Immunochemicals, Agilent Technologies Inc. |
Loading Table Of Content...
